266 related articles for article (PubMed ID: 28687107)
1. Laboratory Approaches for Assessing Contact System Activation.
Christiansen SC; Zuraw BL
Immunol Allergy Clin North Am; 2017 Aug; 37(3):527-539. PubMed ID: 28687107
[TBL] [Abstract][Full Text] [Related]
2. Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization.
Christiansen SC; Zuraw BL
Immunol Allergy Clin North Am; 2024 Aug; 44(3):543-560. PubMed ID: 38937015
[TBL] [Abstract][Full Text] [Related]
3. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
4. Hereditary and acquired complement component 1 esterase inhibitor deficiency: a review for the hematologist.
Cicardi M; Johnston DT
Acta Haematol; 2012; 127(4):208-20. PubMed ID: 22456031
[TBL] [Abstract][Full Text] [Related]
5. Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema.
Lara-Marquez ML; Christiansen SC; Riedl MA; Herschbach J; Zuraw BL
Clin Exp Allergy; 2018 Nov; 48(11):1429-1438. PubMed ID: 29957871
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
Castelli R; Zanichelli A; Cugno M
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
[TBL] [Abstract][Full Text] [Related]
7. Genetic test indications and interpretations in patients with hereditary angioedema.
Weiler CR; van Dellen RG
Mayo Clin Proc; 2006 Jul; 81(7):958-72. PubMed ID: 16835976
[TBL] [Abstract][Full Text] [Related]
8. Angioedema Without Wheals: Challenges in Laboratorial Diagnosis.
Grumach AS; Veronez CL; Csuka D; Farkas H
Front Immunol; 2021; 12():785736. PubMed ID: 34956216
[TBL] [Abstract][Full Text] [Related]
9. HAE Pathophysiology and Underlying Mechanisms.
Zuraw BL; Christiansen SC
Clin Rev Allergy Immunol; 2016 Oct; 51(2):216-29. PubMed ID: 27459852
[TBL] [Abstract][Full Text] [Related]
10. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade.
Kaplan AP; Joseph K
Immunol Allergy Clin North Am; 2017 Aug; 37(3):513-525. PubMed ID: 28687106
[TBL] [Abstract][Full Text] [Related]
12. Hereditary angioedema attack: what happens to vasoactive mediators?
Ferrara AL; Bova M; Petraroli A; Veszeli N; Galdiero MR; Braile M; Marone G; Cristinziano L; Marcella S; Modestino L; Farkas H; Loffredo S
Int Immunopharmacol; 2020 Jan; 78():106079. PubMed ID: 31841756
[TBL] [Abstract][Full Text] [Related]
13. Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema.
Davis AE
Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S7-12. PubMed ID: 18220146
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin-mediated diseases.
Kaplan AP
Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.
Joseph K; Tholanikunnel BG; Wolf B; Bork K; Kaplan AP
J Allergy Clin Immunol; 2016 Jun; 137(6):1822-1829.e1. PubMed ID: 26395818
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for C1 esterase inhibitor deficiency in a Murine Model of Hereditary angioedema.
Qiu T; Chiuchiolo MJ; Whaley AS; Russo AR; Sondhi D; Kaminsky SM; Crystal RG; Pagovich OE
Allergy; 2019 Jun; 74(6):1081-1089. PubMed ID: 30059156
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin: Inflammatory Product of the Coagulation System.
Hofman Z; de Maat S; Hack CE; Maas C
Clin Rev Allergy Immunol; 2016 Oct; 51(2):152-61. PubMed ID: 27122021
[TBL] [Abstract][Full Text] [Related]
18. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Joseph K; Tholanikunnel TE; Kaplan AP
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
[TBL] [Abstract][Full Text] [Related]
19. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
Cugno M; Zanichelli A; Foieni F; Caccia S; Cicardi M
Trends Mol Med; 2009 Feb; 15(2):69-78. PubMed ID: 19162547
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
